Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP324325.RACNvn7y2wRA2t7Td_KY83oocLgu6Hqu1e_hzQ5vDp9i0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP324325.RACNvn7y2wRA2t7Td_KY83oocLgu6Hqu1e_hzQ5vDp9i0130_assertion type Assertion NP324325.RACNvn7y2wRA2t7Td_KY83oocLgu6Hqu1e_hzQ5vDp9i0130_head.
- NP324325.RACNvn7y2wRA2t7Td_KY83oocLgu6Hqu1e_hzQ5vDp9i0130_assertion description "[The high Ile(157)--> Thr(157)mutation frequency (6.5%) observed in healthy controls and the lack of other mutations suggest that CHK2 does not contribute significantly to the hereditary breast cancer or LFL-associated breast cancer risk, at least not in the Finnish population.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324325.RACNvn7y2wRA2t7Td_KY83oocLgu6Hqu1e_hzQ5vDp9i0130_provenance.
- NP324325.RACNvn7y2wRA2t7Td_KY83oocLgu6Hqu1e_hzQ5vDp9i0130_assertion evidence source_evidence_literature NP324325.RACNvn7y2wRA2t7Td_KY83oocLgu6Hqu1e_hzQ5vDp9i0130_provenance.
- NP324325.RACNvn7y2wRA2t7Td_KY83oocLgu6Hqu1e_hzQ5vDp9i0130_assertion SIO_000772 11461078 NP324325.RACNvn7y2wRA2t7Td_KY83oocLgu6Hqu1e_hzQ5vDp9i0130_provenance.
- NP324325.RACNvn7y2wRA2t7Td_KY83oocLgu6Hqu1e_hzQ5vDp9i0130_assertion wasDerivedFrom befree-2016 NP324325.RACNvn7y2wRA2t7Td_KY83oocLgu6Hqu1e_hzQ5vDp9i0130_provenance.
- NP324325.RACNvn7y2wRA2t7Td_KY83oocLgu6Hqu1e_hzQ5vDp9i0130_assertion wasGeneratedBy ECO_0000203 NP324325.RACNvn7y2wRA2t7Td_KY83oocLgu6Hqu1e_hzQ5vDp9i0130_provenance.